Literature DB >> 2274049

Regulation of glycolipid synthesis during differentiation of clonal murine muscle cells.

K C Leskawa1, E L Hogan.   

Abstract

The two clonal murine muscle cell lines G7 and G8, originally derived from the M114 line, represent unique models for comparative studies of myogenesis. Glycolipid synthesis was examined during differentiation using [3H]-galactose and [3H]-glucosamine as precursors. Upon G7 contact glucosylceramide labeling increased and nLcOse5Cer labeling stopped. During membrane fusion, glucosylceramide labeling stopped and lactosylceramide became the major synthetic product. G8 cells presented a different pattern, with increased labeling of GbOse3Cer during myogenesis. The major ganglioside synthesized by both myoblasts was GM3, and more complex structures were observed following completion of myotube formation. Total glycopeptide labeling increased when G8 myoblasts fused and remained elevated in myotubes, whereas no differences during fusion of G7 cells were noted. Upon comparison of the two clonal lines, the only consistent observation was a significant increase in the synthesis of total gangliosides and neutral glycolipid during cell contact and membrane fusion (p less than 0.02). The results suggest that changes in the synthesis of specific glycolipid structures during myogenesis are unique to each muscle cell line examined. However, transient increases in synthesis of total myoblast gangliosides and neutral glycolipids may be a more general phenomenon, possibly by curbing proliferation or by altering myoblast membrane fluidity characteristics during differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274049     DOI: 10.1007/bf00420908

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  57 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

2.  A new procedure for the extraction, purification and fractionation of brain gangliosides.

Authors:  G Tettamanti; F Bonali; S Marchesini; V Zambotti
Journal:  Biochim Biophys Acta       Date:  1973-01-19

3.  Glycolipids and myoblast differentiation [proceedings].

Authors:  F A McEvoy; D E Ellis
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

4.  Ganglioside designation.

Authors:  L Svennerholm
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

5.  Inhibition of myoblast fusion by tunicamycin and pantomycin.

Authors:  B M Gilfix; B D Sanwal
Journal:  Biochem Biophys Res Commun       Date:  1980-10-16       Impact factor: 3.575

6.  Tunicamycin inhibits ganglioside biosynthesis in neuronal cells.

Authors:  S P Guarnaccia; J H Shaper; R L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Glycolipids and their developmental patterns in chick thigh and leg muscles.

Authors:  M Saito; A Rosenberg
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

8.  A simplified procedure for the preparation of tritiated GM1 ganglioside and other glycosphingolipids.

Authors:  K C Leskawa; S Dasgupta; J L Chien; E L Hogan
Journal:  Anal Biochem       Date:  1984-07       Impact factor: 3.365

9.  Ganglioside headgroups decrease lipid order in reconstituted phosphatidylcholine liposomes.

Authors:  M Ollmann; H J Galla
Journal:  FEBS Lett       Date:  1985-01-01       Impact factor: 4.124

10.  Ganglioside headgroup dynamics.

Authors:  P M Lee; N V Ketis; K R Barber; C W Grant
Journal:  Biochim Biophys Acta       Date:  1980-09-18
View more
  7 in total

Review 1.  Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.

Authors:  Mariana N Nikolova-Karakashian; Michael B Reid
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

2.  Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.

Authors:  J Müthing; M Cacić
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

3.  Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates.

Authors:  Mathilde Janot; Aymeric Audfray; Céline Loriol; Agnès Germot; Abderrahman Maftah; Fabrice Dupuy
Journal:  BMC Genomics       Date:  2009-10-20       Impact factor: 3.969

4.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

5.  Expression of neutral glycosphingolipids and gangliosides in human skeletal and heart muscle determined by indirect immunofluorescence staining.

Authors:  M Cacić; J Müthing; I Kracun; U Neumann; S Weber-Schürholz
Journal:  Glycoconj J       Date:  1994-10       Impact factor: 2.916

6.  Glycosphingolipids during skeletal muscle cell differentiation: comparison of normal and fusion-defective myoblasts.

Authors:  L D Cambron; K C Leskawa
Journal:  Mol Cell Biochem       Date:  1994-01-26       Impact factor: 3.396

7.  A role for Galgt1 in skeletal muscle regeneration.

Authors:  Neha Singhal; Paul T Martin
Journal:  Skelet Muscle       Date:  2015-01-27       Impact factor: 4.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.